Compared with control treatment, NLRP12 overexpression significantly increased tumor burden parameters (size/volume/weight), whereas HK2 knockdown significantly decreased these tumorigenic metrics (Fig. 8A–C). The gene discussed is NLRP12; the disease is neoplasm.